You just read:

Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid Drug Dependence

News provided by

Braeburn Pharmaceuticals, Inc.

Jun 13, 2017, 08:03 ET